Figure 5 (IMAGE)

Impact Journals LLC

Figure 5

Caption

NG25 reduce viability of CD138+ cells from patients, alone and in combination with melphalan. (A) CD138+ cells from 10 individual donors were treated with NG25 before cell viability was measured. Individual donors, mean and SD are shown. Asterisks indicate statistically significant differences (Kruskal-Wallis test, Dunn's multiple comparison test, P < 0,05). (B) CD138+ cells from 10 individual donors were treated with melphalan, NG25 or both in technical triplicates. Mean and SD of triplicates from each donor are shown. Single asterisk denotes statistical significance as compared to the control not treated with NG25 for the lowest dose of NG25, double asterisk denotes statistical significance as compared to the untreated control for the highest dose of NG25. Asterisks indicate statistically significant differences (two-way ANOVA, Tukey's multiple comparison test, P < 0,05). All treatments were for 18 hours, and viability was measured by CellTiter-Glo.

Credit

Correspondence to - Kristian K. Starheim - Kristian.starheim@ntnu.no

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.